Scott Megaffin is the founder of Adiso Therapeutics. Backed by Morningside Ventures. Based in Concord, United States.
Scott Megaffin is the Chief Executive Officer of Adiso Therapeutics, a clinical-stage biotechnology company focused on advancing novel therapies for inflammatory diseases. The company is developing a pipeline of small molecules and live biotherapeutic products, including three clinical-stage programs targeting ulcerative colitis and C. difficile. Adiso Therapeutics was launched by Morningside Ventures, which has financed its development plans.
Full founder directory · Investor directory · Company funding database · Fundraising library